A beloved mural depicting the late Brandy Alexander, an icon in Charlotte’s drag queen and LGBTQ communities, was painted ...

A phase 3 trial of nemvaleukin alfa in with Keytruda for patients with platinum-resistant ovarian cancer will not continue on ...

Arsh Pal has two passions in his life: his painting and helping people.On his eighth birthday, Arsh’s family gave him acrylic painting supplies and he became obsessed with the medium, producing ...

Indio has a new mural that's meaning goes beyond creative art. Artist Patrick Barwinski created the "Desi Memorial Mural," in ...

Stock analysts at HC Wainwright issued their Q1 2026 earnings per share (EPS) estimates for Mural Oncology in a research ...

Mural Oncology's stock plummeted 57% after halting the Phase 3 ARTISTRY-7 trial for nemvaleukin alfa. Click here to read an ...

For further information, call 419-332-8696 or visit the Downtown Fremont Inc. office at 315Garrison St., Fremont. Visit ...

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...

Nemvaleukin alfa is an investigational engineered fusion protein composed of modified interleukin-2 (IL-2) and the high-affinity IL-2 alpha receptor chain.

Evaluation of nemvaleukin for platinum-resistant ovarian cancer will be terminated based on OS data from an interim analysis ...

A Waltham company pulled the plug on a Phase 3 cancer trial, while a different Waltham company continued its leadership ...

Mural Oncology (NASDAQ:MURA – Get Free Report) was downgraded by stock analysts at Raymond James from a “strong-buy” rating ...